Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
PARP inhibitors: clinical relevance, mechanisms of action and tumor resistance
The Poly (ADP-ribose) polymerase (PARP) family has many essential functions in cellular
processes, including the regulation of transcription, apoptosis and the DNA damage …
processes, including the regulation of transcription, apoptosis and the DNA damage …
Current status and prospect of ZIF-based materials for breast cancer treatment
Y Zeng, D Liao, X Kong, Q Huang, M Zhong… - Colloids and Surfaces B …, 2023 - Elsevier
Breast cancer, one of the three most life-threatening cancers in modern times, must be
explored for treatments with low side effects and practical efficacy. Metal organic framework …
explored for treatments with low side effects and practical efficacy. Metal organic framework …
Recent advances of nucleic acid-based cancer biomarkers and biosensors
J Zhao, K **a, P He, G Wei, X Zhou, X Zhang - Coordination Chemistry …, 2023 - Elsevier
Nucleic acid-based cancer biomarkers (NABCBs) have emerged as a notable and
continuously captivating research focal point within the domain of oncology. As a result …
continuously captivating research focal point within the domain of oncology. As a result …
Exploring biomarkers in breast cancer: Hallmarks of diagnosis, treatment, and follow-up in clinical practice
L Lopez-Gonzalez, A Sanchez Cendra… - Medicina, 2024 - mdpi.com
Breast cancer is a prevalent malignancy in the present day, particularly affecting women as
one of the most common forms of cancer. A significant portion of patients initially present …
one of the most common forms of cancer. A significant portion of patients initially present …
Therapeutic evolution in HR+/HER2-breast cancer: from targeted therapy to endocrine therapy
Breast cancer, a complex and varied disease, has four distinct subtypes based on estrogen
receptor and human epidermal growth factor receptor 2 (HER2) levels, among which a …
receptor and human epidermal growth factor receptor 2 (HER2) levels, among which a …
The relationship between tobacco and breast cancer incidence: A systematic review and meta-analysis of observational studies
Y He, Y Si, X Li, J Hong, C Yu, N He - Frontiers in oncology, 2022 - frontiersin.org
Background The effect of tobacco on breast cancer (BC) is controversial. The purpose of this
study was to investigate the relationship between tobacco and BC. Methods A search was …
study was to investigate the relationship between tobacco and BC. Methods A search was …
Identifying actionable druggable targets for breast cancer: Mendelian randomization and population-based analyses
Background Drug repurposing provides a cost-effective approach to address the need for
breast cancer prevention and therapeutics. We aimed to identify actionable druggable …
breast cancer prevention and therapeutics. We aimed to identify actionable druggable …
A fully 3D-printed versatile tumor-on-a-chip allows multi-drug screening and correlation with clinical outcomes for personalized medicine
E Steinberg, R Friedman, Y Goldstein… - Communications …, 2023 - nature.com
Optimal clinical outcomes in cancer treatments could be achieved through the development
of reliable, precise ex vivo tumor models that function as drug screening platforms for patient …
of reliable, precise ex vivo tumor models that function as drug screening platforms for patient …
The relationship between dairy products intake and breast cancer incidence: a meta-analysis of observational studies
Y He, Q Tao, F Zhou, Y Si, R Fu, B Xu, J Xu, X Li… - BMC cancer, 2021 - Springer
Background The effect of dairy products intake on breast cancer (BC) is highly controversial.
This study aims to investigate the relationship between dairy intake and BC incidence …
This study aims to investigate the relationship between dairy intake and BC incidence …
Male breast Cancer: current scenario and future perspectives
A Chidambaram, R Prabhakaran… - … in Cancer Research …, 2024 - journals.sagepub.com
Male breast cancer (MBC), one of the rare types of cancer among men where the global
incidence rate is 1.8% of all breast cancers cases with a yearly increase in a pace of 1.1 …
incidence rate is 1.8% of all breast cancers cases with a yearly increase in a pace of 1.1 …